| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/07/1987 | US4678668 Method of reducing soft tissue swelling and pain |
| 07/07/1987 | CA1223868A1 Derivatives of bicyclic aminoacids, processes for their preparation, agents containing these derivatives and their use and new bicyclic aminoacids as intermediates and processesfor their preparation |
| 07/02/1987 | WO1987003908A1 Plasmid and phage clones of human t-cell lymphotropic virus type iii |
| 07/02/1987 | WO1987003906A1 Tissue plasminogen activator (tpa) analogs |
| 07/02/1987 | WO1987003885A1 Human placenta angiogenic factor capable of stimulating capillary endothelial cell protease synthesis, dna synthesis and migration |
| 07/02/1987 | WO1987003884A1 New analogues of hypocalcemic polypeptidic compounds saving the calcium of the organism, preparation thereof, application thereof as medicaments and compositions containing them |
| 07/02/1987 | WO1987003883A2 Use of oligopeptides in the treatment of viral infections |
| 07/02/1987 | WO1987003878A1 New 8-substituted derivatives of an anhydrooctonic acid, methods for their preparation, pharmaceutical preparations containing these and intermediates |
| 07/02/1987 | WO1987003812A1 Method for healing bone damage and composition |
| 07/02/1987 | WO1987003811A1 Method for treatment of angina and myocardial infarctions with omental lipids |
| 07/02/1987 | WO1987003810A1 Nutrient compositions deprived of methionine and supplemented with homocysteine |
| 07/02/1987 | WO1987003806A1 Parenteral nutrition therapy with amino acids |
| 07/01/1987 | EP0227627A2 Composition and method for osseous repair |
| 07/01/1987 | EP0227619A2 New protein and its use |
| 07/01/1987 | EP0227462A2 Novel peptide plasminogen activators |
| 07/01/1987 | EP0227410A2 Peptide derivatives, their production and use |
| 07/01/1987 | EP0227400A2 Inhibition of post-surgical adhesion formation by the topical administration of tissue plasminogen activator |
| 07/01/1987 | EP0227391A2 Parathyroid-specific radioimaging techniques |
| 07/01/1987 | EP0227306A2 Peptide immunostimulants |
| 07/01/1987 | EP0227102A2 Cell line established from human normal uterine muscle, method for producing plasminogen activator using the cell line, and plasminogen activator |
| 07/01/1987 | EP0226800A2 Novel recombinant gene and use thereof |
| 07/01/1987 | EP0226603A1 Use of tumor necrosis factor as a weight regulator |
| 07/01/1987 | CN86108300A Mutant coding sequence |
| 07/01/1987 | CN86107931A Peptide containing immunoexcitant |
| 07/01/1987 | CN86104458A Purification of hemoglobin and modified hemoglobin by affinity chromatography |
| 06/30/1987 | US4677197 Purification method for tumor necrosis factor |
| 06/30/1987 | US4677195 Method for the purification of erythropoietin and erythropoietin compositions |
| 06/30/1987 | US4677193 Peptides containing an aliphatic-aromatic ketone side chain |
| 06/30/1987 | US4677192 Chromatography with mixed chloroform, methanol, water, and triethylamine eluant |
| 06/30/1987 | US4677125 Phosphorus-containing peptide derivatives |
| 06/30/1987 | US4677070 Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use |
| 06/30/1987 | US4677064 Human tumor necrosis factor |
| 06/30/1987 | US4677063 Human tumor necrosis factor |
| 06/30/1987 | US4676983 Tumor cytostatic-citocidal factor from blood platelets |
| 06/30/1987 | US4676982 Treatment of chronic inflammatory disease with polyvalent immunoglobulins |
| 06/30/1987 | CA1223513A1 Diagnosis and treatment of amyotrophic lateral sclerosis, parkinson disease and alzheimer disease by neurotrophic factors |
| 06/25/1987 | EP0192738A4 Expression of human connective tissue activator and related peptides. |
| 06/24/1987 | EP0226513A1 Peptides capable of inhibiting interactions between antigens and lymphocytes T4, products derived therefrom and their applications |
| 06/24/1987 | EP0226443A2 Human conglutinin |
| 06/24/1987 | EP0226419A2 Anti-human ovarian cancer immunotoxins and methods of use thereof |
| 06/24/1987 | EP0226418A2 Anti-human ovarian cancer immunotoxins and methods of use thereof |
| 06/24/1987 | EP0226312A2 Treating increased intraocular pressure by steroids |
| 06/24/1987 | EP0226217A2 Peptides with sulfate ester group |
| 06/24/1987 | EP0226181A2 Human placenta angiogenic factor capable of stimulating capillary endothelial cell protease synthesis, DNA synthesis and migration |
| 06/24/1987 | EP0226175A1 Process for preparing an improved composition of the zinc salt of bacitracin for veterinary use as growth promoter |
| 06/24/1987 | EP0226172A2 Agent for the treatment of thrombosis consisting of a plasmin inhibitor and a plasminogen activator |
| 06/24/1987 | EP0226158A2 Peptides correlated to lysozyme |
| 06/24/1987 | EP0225878A1 Medicinal composition and method for the treatment of periarthritis and similar diseases |
| 06/24/1987 | EP0131477B1 Use of a salt of the acid n-acetyl (alpha, beta) aspartylglutamic for the manufacture of a drug having an anti-allergic activity for local administration |
| 06/23/1987 | US4675387 Lymphs + cells bilogical |
| 06/23/1987 | US4675384 Fractionation/purification of plasma by ion exchange chromatography |
| 06/23/1987 | US4675382 Anticarcinogenic agents; polypeptide linkages |
| 06/23/1987 | US4675381 Biodegradable polypeptide and its use for the gradual release of drugs |
| 06/23/1987 | US4675338 Peptide linkages with aspartic and glutamic acid; antitumor a gents |
| 06/23/1987 | US4675310 Liposome composition as gas transport agents |
| 06/23/1987 | US4675287 Monoclonal antibody directed to human ganglioside GD2 |
| 06/23/1987 | US4675282 Assay for interferon epsilon |
| 06/23/1987 | US4675196 Ion exchange resin |
| 06/23/1987 | US4675189 Microencapsulation of water soluble active polypeptides |
| 06/23/1987 | US4675184 Viricides |
| 06/23/1987 | US4675183 Method for solubilization of interferon |
| 06/23/1987 | US4675176 Eye disorders |
| 06/23/1987 | CA1223382A1 Immobilization of proteins on polymeric supports |
| 06/23/1987 | CA1223207A1 Gamma interferon composition |
| 06/23/1987 | CA1223204A1 Method for controlling hemophilia in mammals |
| 06/23/1987 | CA1223203A1 Protein compositions substantially free from infectious agents |
| 06/23/1987 | CA1223202A1 Fibronectin-physiologically active substance complex and method of preparation thereof |
| 06/23/1987 | CA1223201A1 Process for the preparation of the c1 inactivator and its use |
| 06/23/1987 | CA1223200A1 Pharmaceutical compositions containing insulin |
| 06/23/1987 | CA1223199A1 Partially purified osteogenic factor and process for preparing same from demineralized bone |
| 06/23/1987 | CA1223198A1 Repair of tissue in animals |
| 06/18/1987 | WO1987003602A1 Anticytomegaloviral human monoclonal antibody and process for its preparation |
| 06/18/1987 | WO1987003601A1 Peptides capable of inhibiting the interactions between antigens and lymphocytes t4, products derived therefrom and application thereof |
| 06/18/1987 | WO1987003600A1 Cell-free t cell antigen receptor and its clinical utilities |
| 06/18/1987 | WO1987003489A1 Combinations of tumor necrosis factors and antibiotics and methods for treating tumors |
| 06/18/1987 | WO1987003488A1 Treatment of thrombosis with fibrinolytic agents and prostacyclines |
| 06/18/1987 | WO1987003487A1 Methods and materials for alleviation of pain symptoms of malignant neoplasia |
| 06/18/1987 | WO1987003486A1 Method for enhancement of healing of epithelial wounds in mammals |
| 06/18/1987 | WO1987003485A1 Compositions for combatting diarrhoea |
| 06/18/1987 | WO1987003480A2 Medicament with anti-tumoral action containing hexadecylphosphocholine |
| 06/18/1987 | WO1987003478A2 Medicaments |
| 06/17/1987 | CN86106234A Production of pluripotent granule cell colony stimulating factor |
| 06/16/1987 | US4673733 Treatment of biological and pharmaceutical products adsorbed on a solid phase with virus and pyrogen inactivating agents |
| 06/16/1987 | US4673732 A-human atrial natriuretic polypeptide; diaonosis of hypertension |
| 06/16/1987 | US4673665 Induce ovulation by using a gestagen followed by luteinizing hormone |
| 06/16/1987 | US4673573 Novel fibrinolytic enzyme compounds |
| 06/16/1987 | EP0225796A2 Novel crystals of N alpha-[[(S)-4-oxo-2-azetidinyl]-carbonyl]-L-histidyl-L-prolinamide and process for producing the crystals |
| 06/16/1987 | EP0225759A2 Interferon compositions |
| 06/16/1987 | EP0225746A2 Therapeutic decapeptides |
| 06/16/1987 | EP0225633A2 Production of thrombin inhibitors |
| 06/16/1987 | EP0225608A2 Medicine |
| 06/16/1987 | EP0225602A2 Alpha-hydroxythio ethers |
| 06/16/1987 | EP0225583A2 Monoclonal anti-human granulocyte colony stimulating factor antibody |
| 06/16/1987 | EP0225579A2 Covalently linked polypeptide cell modulators |
| 06/16/1987 | EP0225386A1 Bradykinin antagonist peptides |
| 06/16/1987 | CA1222952A1 Mixtures of fsh and lh from pig hypophyses in a definite ratio |
| 06/16/1987 | CA1222948A1 Enhancement of intranasal absorption of calcitonin by formulation with surfactants |
| 06/15/1987 | EP0148922A4 Hybrid dna synthesis of epidermal growth factor. |
| 06/11/1987 | DE3642050A1 New killer toxin |
| 06/11/1987 | DE3640042A1 Novel calcitonin derivatives |